Key Insights
The UK respiratory medical devices market is poised for significant expansion, driven by increasing respiratory disease prevalence and an aging demographic. Demand for advanced diagnostic and therapeutic solutions is escalating. Technological innovation, including portable and user-friendly devices, along with rising healthcare investments, are key growth catalysts.
UK Respiratory Medical Devices Industry Market Size (In Billion)
The market size is projected to reach £19.07 billion by 2025, with a Compound Annual Growth Rate (CAGR) of 5.6%. This projection is based on a comprehensive analysis of the global market and the UK's substantial share within the European region, accounting for healthcare costs and respiratory illness burden. The market is segmented into diagnostic, therapeutic, and disposable devices, with therapeutic solutions anticipated to dominate due to growing patient needs for continuous respiratory support.
UK Respiratory Medical Devices Industry Company Market Share
Key industry players, including ResMed, Philips, and Fisher & Paykel Healthcare, are actively engaged in innovation and strategic alliances to capture market share.
The forecast period (2025-2033) anticipates sustained growth, fueled by advancements in telemonitoring, digital therapeutics, and a greater focus on preventative care and early disease detection. Challenges such as pricing pressures and regulatory complexities may impact expansion, alongside potential economic fluctuations and policy changes. Nevertheless, the overarching outlook for the UK respiratory medical devices market remains strong, driven by the continuous and growing demand for effective respiratory care.
UK Respiratory Medical Devices Industry: 2019-2033 Market Report
This comprehensive report provides a detailed analysis of the UK respiratory medical devices industry, offering invaluable insights for stakeholders across the value chain. Covering the period 2019-2033, with a focus on 2025, this report unveils market trends, growth drivers, challenges, and opportunities within this dynamic sector. The report leverages extensive market research, incorporating data and analysis from various sources, to paint a clear picture of the current landscape and future trajectory. Expect actionable insights to inform strategic decision-making.
UK Respiratory Medical Devices Industry Market Concentration & Innovation
This section analyzes the UK respiratory medical devices market's competitive landscape, examining market concentration, innovation drivers, regulatory frameworks, product substitutes, end-user trends, and M&A activities. The market is characterized by a mix of large multinational corporations and smaller specialized companies. Key players like Medtronic PLC, Invacare Corporation, Koninklijke Philips NV, DeVilbiss Healthcare LLC, ResMed Inc, GE Healthcare, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, and GlaxoSmithKline PLC hold significant market share, though the exact figures vary by segment.
- Market Concentration: The Herfindahl-Hirschman Index (HHI) for the UK respiratory medical devices market in 2024 is estimated at xx, indicating a moderately concentrated market.
- Innovation Drivers: Growing prevalence of respiratory diseases, technological advancements in device miniaturization and connectivity, and increasing demand for home healthcare solutions are key innovation drivers.
- Regulatory Framework: The Medicines and Healthcare products Regulatory Agency (MHRA) plays a crucial role in regulating medical devices, impacting product development and market entry.
- Product Substitutes: The availability of alternative therapies and treatments can affect market growth, though the severity and chronic nature of many respiratory conditions often limits substitution.
- End-User Trends: Increasing patient awareness, demand for improved device usability, and preference for connected health solutions are shaping end-user preferences.
- M&A Activities: The total value of M&A deals in the UK respiratory medical devices sector between 2019 and 2024 is estimated at £xx Million. These activities often reflect strategic moves to expand product portfolios and enhance market reach.
UK Respiratory Medical Devices Industry Industry Trends & Insights
The UK respiratory medical devices market experienced significant growth during the historical period (2019-2024), driven by several factors. The rising prevalence of chronic respiratory diseases like asthma, COPD, and sleep apnea fuels demand for diagnostic and therapeutic devices. Technological advancements have resulted in more sophisticated, portable, and user-friendly devices. An aging population, coupled with increased healthcare expenditure, further supports market expansion. The market's Compound Annual Growth Rate (CAGR) during 2019-2024 was approximately xx%, with market penetration rates varying across different segments. The increasing adoption of telehealth and remote patient monitoring technologies is disrupting traditional healthcare delivery models, offering opportunities for growth in connected devices and associated services. Competitive dynamics are shaped by product innovation, pricing strategies, and strategic partnerships.
Dominant Markets & Segments in UK Respiratory Medical Devices Industry
The UK market is geographically concentrated, with major demand emanating from urban areas with higher population density and healthcare infrastructure. Within the segment breakdown:
By Diagnostic and Monitoring Devices: Pulse oximeters and spirometers hold a significant market share due to their widespread use in both clinical and home settings. The growing demand for early detection and effective management of respiratory diseases is driving segment growth. Growth drivers include:
- Increased awareness of respiratory conditions among the general population.
- Technological advancements leading to improved accuracy and user-friendliness.
- Rising adoption of home-based testing and monitoring.
By Therapeutic Devices: The therapeutic devices segment dominates the market, with CPAP devices, nebulizers, and inhalers being the major contributors. The increasing prevalence of sleep apnea and other respiratory conditions requiring continuous therapy is a key driver. Growth drivers include:
- Rising prevalence of chronic respiratory diseases.
- Advances in device technology leading to improved efficacy and comfort.
- Growing preference for non-invasive ventilation options.
By Disposables: Masks and breathing circuits are major contributors to this segment. The growing demand for disposable medical devices for infection control contributes to market expansion. Growth drivers include:
- Increased focus on infection control and hygiene practices in healthcare settings.
- Rising demand for single-use disposable devices.
- Advances in material technology offering improved performance and patient comfort.
UK Respiratory Medical Devices Industry Product Developments
Recent product innovations focus on improving device portability, connectivity, and ease of use. Miniaturization of devices, integration of smart technologies, and development of user-friendly interfaces enhance patient compliance and therapeutic efficacy. Manufacturers are increasingly incorporating data analytics and remote monitoring capabilities to improve patient outcomes and reduce hospital readmissions. This trend caters to a growing preference for remote patient monitoring and the increasing affordability of smart devices.
Report Scope & Segmentation Analysis
This report comprehensively analyzes the UK respiratory medical devices market across three primary segments: Diagnostic and Monitoring Devices, Therapeutic Devices, and Disposables. Each segment is further broken down into sub-segments, providing a granular view of market dynamics. The report provides detailed insights into market size, growth projections, and competitive dynamics for each segment. Market size projections for 2033 indicate a substantial increase across all segments, reflecting the anticipated rise in prevalence of respiratory conditions and technological advancements.
Key Drivers of UK Respiratory Medical Devices Industry Growth
Several factors contribute to the growth of the UK respiratory medical devices market. Technological advancements resulting in smaller, more user-friendly, and connected devices are a key factor. The rising prevalence of chronic respiratory diseases, particularly among an aging population, fuels demand. Government initiatives aimed at improving healthcare access and quality further bolster market expansion. Finally, increasing healthcare expenditure supports investments in advanced medical technologies.
Challenges in the UK Respiratory Medical Devices Industry Sector
The UK respiratory medical devices industry faces several challenges. Stringent regulatory requirements can prolong product development timelines and increase costs. Supply chain disruptions can affect the availability of essential components and materials. Intense competition from established players and emerging market entrants necessitates continuous innovation and cost optimization strategies. The impact of these factors is reflected in fluctuating market growth rates across different segments.
Emerging Opportunities in UK Respiratory Medical Devices Industry
Emerging opportunities arise from the growing adoption of telehealth and remote patient monitoring, expanding demand for personalized medicine solutions, and increasing focus on preventive care. The development of innovative diagnostic tools for early disease detection presents significant potential. The use of AI and machine learning to personalize treatment plans and improve patient outcomes also offers substantial growth prospects.
Leading Players in the UK Respiratory Medical Devices Industry Market
- Medtronic PLC
- Invacare Corporation
- Koninklijke Philips NV
- DeVilbiss Healthcare LLC
- ResMed Inc
- GE Healthcare
- Dragerwerk AG
- Fisher & Paykel Healthcare Ltd
- GlaxoSmithKline PLC
Key Developments in UK Respiratory Medical Devices Industry Industry
- May 2022: Honeywell launched two new NIOSH-certified respiratory offerings, including the DC365 Small Surgical N95 Respirator, targeting frontline healthcare workers.
- January 2022: Responsive Respiratory released a new Product Solutions catalog, featuring the Purify O3 Elite Sanitizer for PAP accessories, expanding its product portfolio.
Strategic Outlook for UK Respiratory Medical Devices Industry Market
The UK respiratory medical devices market is poised for significant growth over the forecast period (2025-2033), driven by a confluence of factors, including rising prevalence of respiratory diseases, technological advancements, increasing healthcare spending, and supportive government policies. Strategic investments in research and development, expansion into new market segments, and adoption of innovative business models will be critical for sustained growth. The market offers attractive opportunities for both established players and new entrants, especially in areas like connected devices, AI-powered diagnostics, and personalized therapies.
UK Respiratory Medical Devices Industry Segmentation
-
1. Type
-
1.1. By Diagnostic and Monitoring Devices
- 1.1.1. Spirometers
- 1.1.2. Sleep Test Devices
- 1.1.3. Peak Flow Meters
- 1.1.4. Pulse Oximeters
- 1.1.5. Capnographs
- 1.1.6. Other Diagnostic and Monitoring Devices
-
1.2. By Therapeutic Devices
- 1.2.1. CPAP Devices
- 1.2.2. BiPAP Devices
- 1.2.3. Humidifiers
- 1.2.4. Nebulizers
- 1.2.5. Oxygen Concentrators
- 1.2.6. Ventilators
- 1.2.7. Inhalers
- 1.2.8. Other Therapeutic Devices
-
1.3. By Disposables
- 1.3.1. Masks
- 1.3.2. Breathing Circuits
- 1.3.3. Other Disposables
-
1.1. By Diagnostic and Monitoring Devices
UK Respiratory Medical Devices Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
UK Respiratory Medical Devices Industry Regional Market Share
Geographic Coverage of UK Respiratory Medical Devices Industry
UK Respiratory Medical Devices Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 5.6% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Increasing Prevalence of Respiratory Disorders
- 3.2.2 such as COPD
- 3.2.3 Asthma
- 3.2.4 and Sleep Apnea; Technological Advancements and Increasing Applications in Home Care Settings
- 3.3. Market Restrains
- 3.3.1. High Cost of Devices
- 3.4. Market Trends
- 3.4.1. Spirometers are Expected to be the Dominant Sub-segment in Diagnostic and Monitoring Devices Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global UK Respiratory Medical Devices Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. By Diagnostic and Monitoring Devices
- 5.1.1.1. Spirometers
- 5.1.1.2. Sleep Test Devices
- 5.1.1.3. Peak Flow Meters
- 5.1.1.4. Pulse Oximeters
- 5.1.1.5. Capnographs
- 5.1.1.6. Other Diagnostic and Monitoring Devices
- 5.1.2. By Therapeutic Devices
- 5.1.2.1. CPAP Devices
- 5.1.2.2. BiPAP Devices
- 5.1.2.3. Humidifiers
- 5.1.2.4. Nebulizers
- 5.1.2.5. Oxygen Concentrators
- 5.1.2.6. Ventilators
- 5.1.2.7. Inhalers
- 5.1.2.8. Other Therapeutic Devices
- 5.1.3. By Disposables
- 5.1.3.1. Masks
- 5.1.3.2. Breathing Circuits
- 5.1.3.3. Other Disposables
- 5.1.1. By Diagnostic and Monitoring Devices
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. North America
- 5.2.2. South America
- 5.2.3. Europe
- 5.2.4. Middle East & Africa
- 5.2.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America UK Respiratory Medical Devices Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. By Diagnostic and Monitoring Devices
- 6.1.1.1. Spirometers
- 6.1.1.2. Sleep Test Devices
- 6.1.1.3. Peak Flow Meters
- 6.1.1.4. Pulse Oximeters
- 6.1.1.5. Capnographs
- 6.1.1.6. Other Diagnostic and Monitoring Devices
- 6.1.2. By Therapeutic Devices
- 6.1.2.1. CPAP Devices
- 6.1.2.2. BiPAP Devices
- 6.1.2.3. Humidifiers
- 6.1.2.4. Nebulizers
- 6.1.2.5. Oxygen Concentrators
- 6.1.2.6. Ventilators
- 6.1.2.7. Inhalers
- 6.1.2.8. Other Therapeutic Devices
- 6.1.3. By Disposables
- 6.1.3.1. Masks
- 6.1.3.2. Breathing Circuits
- 6.1.3.3. Other Disposables
- 6.1.1. By Diagnostic and Monitoring Devices
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. South America UK Respiratory Medical Devices Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. By Diagnostic and Monitoring Devices
- 7.1.1.1. Spirometers
- 7.1.1.2. Sleep Test Devices
- 7.1.1.3. Peak Flow Meters
- 7.1.1.4. Pulse Oximeters
- 7.1.1.5. Capnographs
- 7.1.1.6. Other Diagnostic and Monitoring Devices
- 7.1.2. By Therapeutic Devices
- 7.1.2.1. CPAP Devices
- 7.1.2.2. BiPAP Devices
- 7.1.2.3. Humidifiers
- 7.1.2.4. Nebulizers
- 7.1.2.5. Oxygen Concentrators
- 7.1.2.6. Ventilators
- 7.1.2.7. Inhalers
- 7.1.2.8. Other Therapeutic Devices
- 7.1.3. By Disposables
- 7.1.3.1. Masks
- 7.1.3.2. Breathing Circuits
- 7.1.3.3. Other Disposables
- 7.1.1. By Diagnostic and Monitoring Devices
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Europe UK Respiratory Medical Devices Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. By Diagnostic and Monitoring Devices
- 8.1.1.1. Spirometers
- 8.1.1.2. Sleep Test Devices
- 8.1.1.3. Peak Flow Meters
- 8.1.1.4. Pulse Oximeters
- 8.1.1.5. Capnographs
- 8.1.1.6. Other Diagnostic and Monitoring Devices
- 8.1.2. By Therapeutic Devices
- 8.1.2.1. CPAP Devices
- 8.1.2.2. BiPAP Devices
- 8.1.2.3. Humidifiers
- 8.1.2.4. Nebulizers
- 8.1.2.5. Oxygen Concentrators
- 8.1.2.6. Ventilators
- 8.1.2.7. Inhalers
- 8.1.2.8. Other Therapeutic Devices
- 8.1.3. By Disposables
- 8.1.3.1. Masks
- 8.1.3.2. Breathing Circuits
- 8.1.3.3. Other Disposables
- 8.1.1. By Diagnostic and Monitoring Devices
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East & Africa UK Respiratory Medical Devices Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. By Diagnostic and Monitoring Devices
- 9.1.1.1. Spirometers
- 9.1.1.2. Sleep Test Devices
- 9.1.1.3. Peak Flow Meters
- 9.1.1.4. Pulse Oximeters
- 9.1.1.5. Capnographs
- 9.1.1.6. Other Diagnostic and Monitoring Devices
- 9.1.2. By Therapeutic Devices
- 9.1.2.1. CPAP Devices
- 9.1.2.2. BiPAP Devices
- 9.1.2.3. Humidifiers
- 9.1.2.4. Nebulizers
- 9.1.2.5. Oxygen Concentrators
- 9.1.2.6. Ventilators
- 9.1.2.7. Inhalers
- 9.1.2.8. Other Therapeutic Devices
- 9.1.3. By Disposables
- 9.1.3.1. Masks
- 9.1.3.2. Breathing Circuits
- 9.1.3.3. Other Disposables
- 9.1.1. By Diagnostic and Monitoring Devices
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. Asia Pacific UK Respiratory Medical Devices Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. By Diagnostic and Monitoring Devices
- 10.1.1.1. Spirometers
- 10.1.1.2. Sleep Test Devices
- 10.1.1.3. Peak Flow Meters
- 10.1.1.4. Pulse Oximeters
- 10.1.1.5. Capnographs
- 10.1.1.6. Other Diagnostic and Monitoring Devices
- 10.1.2. By Therapeutic Devices
- 10.1.2.1. CPAP Devices
- 10.1.2.2. BiPAP Devices
- 10.1.2.3. Humidifiers
- 10.1.2.4. Nebulizers
- 10.1.2.5. Oxygen Concentrators
- 10.1.2.6. Ventilators
- 10.1.2.7. Inhalers
- 10.1.2.8. Other Therapeutic Devices
- 10.1.3. By Disposables
- 10.1.3.1. Masks
- 10.1.3.2. Breathing Circuits
- 10.1.3.3. Other Disposables
- 10.1.1. By Diagnostic and Monitoring Devices
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Medtronic PLC
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Invacare Corporation*List Not Exhaustive
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Koninklijke Philips NV
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 DeVilbiss Healthcare LLC
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 ResMed Inc
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 GE Healthcare
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Dragerwerk AG
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Fisher & Paykel Healthcare Ltd
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 GlaxoSmithKline PLC
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.1 Medtronic PLC
List of Figures
- Figure 1: Global UK Respiratory Medical Devices Industry Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America UK Respiratory Medical Devices Industry Revenue (billion), by Type 2025 & 2033
- Figure 3: North America UK Respiratory Medical Devices Industry Revenue Share (%), by Type 2025 & 2033
- Figure 4: North America UK Respiratory Medical Devices Industry Revenue (billion), by Country 2025 & 2033
- Figure 5: North America UK Respiratory Medical Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 6: South America UK Respiratory Medical Devices Industry Revenue (billion), by Type 2025 & 2033
- Figure 7: South America UK Respiratory Medical Devices Industry Revenue Share (%), by Type 2025 & 2033
- Figure 8: South America UK Respiratory Medical Devices Industry Revenue (billion), by Country 2025 & 2033
- Figure 9: South America UK Respiratory Medical Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 10: Europe UK Respiratory Medical Devices Industry Revenue (billion), by Type 2025 & 2033
- Figure 11: Europe UK Respiratory Medical Devices Industry Revenue Share (%), by Type 2025 & 2033
- Figure 12: Europe UK Respiratory Medical Devices Industry Revenue (billion), by Country 2025 & 2033
- Figure 13: Europe UK Respiratory Medical Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 14: Middle East & Africa UK Respiratory Medical Devices Industry Revenue (billion), by Type 2025 & 2033
- Figure 15: Middle East & Africa UK Respiratory Medical Devices Industry Revenue Share (%), by Type 2025 & 2033
- Figure 16: Middle East & Africa UK Respiratory Medical Devices Industry Revenue (billion), by Country 2025 & 2033
- Figure 17: Middle East & Africa UK Respiratory Medical Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: Asia Pacific UK Respiratory Medical Devices Industry Revenue (billion), by Type 2025 & 2033
- Figure 19: Asia Pacific UK Respiratory Medical Devices Industry Revenue Share (%), by Type 2025 & 2033
- Figure 20: Asia Pacific UK Respiratory Medical Devices Industry Revenue (billion), by Country 2025 & 2033
- Figure 21: Asia Pacific UK Respiratory Medical Devices Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 2: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Region 2020 & 2033
- Table 3: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 4: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 5: United States UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 6: Canada UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 7: Mexico UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 8: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 9: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 10: Brazil UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 11: Argentina UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 12: Rest of South America UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 13: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 14: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 15: United Kingdom UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 16: Germany UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 17: France UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 18: Italy UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 19: Spain UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 20: Russia UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 21: Benelux UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 22: Nordics UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 23: Rest of Europe UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 24: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 25: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 26: Turkey UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Israel UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: GCC UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 29: North Africa UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 30: South Africa UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 31: Rest of Middle East & Africa UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 32: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 33: Global UK Respiratory Medical Devices Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 34: China UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 35: India UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 36: Japan UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 37: South Korea UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 38: ASEAN UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 39: Oceania UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 40: Rest of Asia Pacific UK Respiratory Medical Devices Industry Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the UK Respiratory Medical Devices Industry?
The projected CAGR is approximately 5.6%.
2. Which companies are prominent players in the UK Respiratory Medical Devices Industry?
Key companies in the market include Medtronic PLC, Invacare Corporation*List Not Exhaustive, Koninklijke Philips NV, DeVilbiss Healthcare LLC, ResMed Inc, GE Healthcare, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GlaxoSmithKline PLC.
3. What are the main segments of the UK Respiratory Medical Devices Industry?
The market segments include Type.
4. Can you provide details about the market size?
The market size is estimated to be USD 19.07 billion as of 2022.
5. What are some drivers contributing to market growth?
Increasing Prevalence of Respiratory Disorders. such as COPD. Asthma. and Sleep Apnea; Technological Advancements and Increasing Applications in Home Care Settings.
6. What are the notable trends driving market growth?
Spirometers are Expected to be the Dominant Sub-segment in Diagnostic and Monitoring Devices Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Devices.
8. Can you provide examples of recent developments in the market?
In May 2022, Honeywell launched two new NIOSH-certified respiratory offerings to help meet the needs of healthcare workers. The DC365 Small Surgical N95 Respirator was launched to help protect frontline workers who need a smaller-sized surgical N95.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "UK Respiratory Medical Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the UK Respiratory Medical Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the UK Respiratory Medical Devices Industry?
To stay informed about further developments, trends, and reports in the UK Respiratory Medical Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence